Company Filing History:
Years Active: 2025
Title: Jan Wehkamp: Innovator in Antimicrobial Peptides
Introduction
Jan Wehkamp is a notable inventor based in Reutlingen, Germany. He has made significant contributions to the field of antimicrobial peptides, particularly in the modulation of the microbiome. His work focuses on developing new therapeutic options for various bodily surfaces.
Latest Patents
Jan Wehkamp holds a patent for "Defensin fragments for use in therapy or prophylaxis." This invention relates to new peptides derived from HD-5 or HNP-4 that exhibit antimicrobial activity. These peptides are designed for use in modulating the microbiome of intestines, lungs, skin, mouth, eyes, ears, vagina, or other bodily surfaces. Additionally, they can serve as antimicrobial agents in humans and other mammals, as well as in medicaments containing these peptides.
Career Highlights
Throughout his career, Jan has worked with several companies, including Aesculus Bio ApS and Defensin Therapeutics ApS. His experience in these organizations has allowed him to advance his research and development in the field of antimicrobial therapies.
Collaborations
Jan has collaborated with notable professionals in his field, including Dirk Ehmann and Peter Nordkild. These partnerships have contributed to the success of his projects and innovations.
Conclusion
Jan Wehkamp is a pioneering inventor whose work in antimicrobial peptides has the potential to impact therapeutic practices significantly. His dedication to advancing medical science through innovation is commendable.